
|Videos|October 11, 2016
Evidence and Outcomes in Atopic Dermatitis
Advertisement
Panelists Peter L. Salgo, MD; Jeffrey D. Dunn, PharmD, MBA; Ed Pezalla, MD, MPH; Jonathan Silverberg, MD, PhD, MPH; and Cheryl Allen, BS Pharm, MBA, provide insight on the evidence and outcomes in atopic dermatitis and how they impact coverage.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times - Pharmacy Practice News and Expert Insights
1
Evinacumab-dgnb Approved For Children Aged 1-5 With Rare Form of High Cholesterol
2
Patients Critically Ill With COVID-19 Have Heightened Risk of Pulmonary Fibrosis
3
Understanding RSV in Older Adults: Risks, Symptoms, and Barriers to Vaccination
4
Stelara Biosimilar SYSA1902 Shows Clinical Equivalence for Plaque Psoriasis
5